Education
About Us
Working with TipRanks
Follow Us
DENTSPLY SIRONA Inc (XRAY)
NASDAQ:XRAY
XRAY Stock Chart & Stats
$11.28
-$0.04(-0.21%)
At close: 4:00 PM EST
$11.28
-$0.04(-0.21%)
Day’s Range― - ―
52-Week Range$9.85 - $20.60
Previous CloseN/A
Volume461.38K
Average Volume (3M)4.00M
Market Cap
$2.28B
Enterprise Value$4.65B
Total Cash (Recent Filing)$363.00M
Total Debt (Recent Filing)$2.48B
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Feb 26, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend Yield5.61%
Share Statistics
EPS (TTM)0.37
Shares Outstanding199,551,970
10 Day Avg. Volume3,555,239
30 Day Avg. Volume4,002,225
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.99
Price to Sales (P/S)1.02
P/FCF Ratio13.73
Enterprise Value/Market Cap2.04
Enterprise Value/Revenue1.28
Enterprise Value/Gross Profit2.52
Enterprise Value/Ebitda-10.76
Forecast
1Y Price Target
$13.27Price Target Upside17.64% Upside
Rating ConsensusHold
Number of Analyst Covering16
EPS Forecast (FY)1.61
Revenue Forecast (FY)$3.65B
Bulls Say, Bears Say
Bulls Say
Interest Rates And Borrowing EnvironmentThe borrowing environment for dental practices should improve with likely sustained or further interest rate cuts in 2026, benefiting capital equipment purchases.
Revenue And Margin ImprovementOperating expenses as a percentage of revenue are expected to improve by 280 basis points compared to the previous year.
Valuation And Market PotentialDentsply Sirona is currently trading over 44% below its 52-week highs and over 80% below its five-year highs, suggesting potential for a significant rally if business conditions improve.
Bears Say
EPS And Financial PerformanceQ3 results fell short with adjusted EPS of $0.37, missing the estimate of $0.45 due to a soft gross margin and higher-than-anticipated operating expenses.
Leadership And Guidance ChallengesThe combination of worse-than-expected results, lowered guidance, and (another) CFO transition, has led shares to trade down more than 10%.
Profitability And Guidance RevisionManagement has already signaled much of the likely bad news, including profitability weakness in the first half of 2026.
DENTSPLY SIRONA News
XRAY FAQ
What was DENTSPLY SIRONA Inc’s price range in the past 12 months?
DENTSPLY SIRONA Inc lowest stock price was $9.85 and its highest was $20.59 in the past 12 months.
What is DENTSPLY SIRONA Inc’s market cap?
DENTSPLY SIRONA Inc’s market cap is $2.28B.
When is DENTSPLY SIRONA Inc’s upcoming earnings report date?
DENTSPLY SIRONA Inc’s upcoming earnings report date is Feb 26, 2026 which is in 69 days.
How were DENTSPLY SIRONA Inc’s earnings last quarter?
DENTSPLY SIRONA Inc released its earnings results on Nov 06, 2025. The company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.448 by -$0.078.
Is DENTSPLY SIRONA Inc overvalued?
According to Wall Street analysts DENTSPLY SIRONA Inc’s price is currently Undervalued.
Does DENTSPLY SIRONA Inc pay dividends?
DENTSPLY SIRONA Inc pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 5.61%. See more information on DENTSPLY SIRONA Inc dividends here
What is DENTSPLY SIRONA Inc’s EPS estimate?
DENTSPLY SIRONA Inc’s EPS estimate is 0.3.
How many shares outstanding does DENTSPLY SIRONA Inc have?
DENTSPLY SIRONA Inc has 199,551,970 shares outstanding.
What happened to DENTSPLY SIRONA Inc’s price movement after its last earnings report?
DENTSPLY SIRONA Inc reported an EPS of $0.37 in its last earnings report, missing expectations of $0.448. Following the earnings report the stock price went down -12.678%.
Which hedge fund is a major shareholder of DENTSPLY SIRONA Inc?
Currently, no hedge funds are holding shares in XRAY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DENTSPLY SIRONA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$13.27 (17.64% Upside)
$13.27 (17.64% Upside)
Blogger Sentiment
Bullish
XRAY Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $815.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 1.9%
Last 30 Days ▼ 6.3%
Last 30 Days ▼ 6.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.89%
12-Months-Change
Fundamentals
Return on Equity
-44.44%
Trailing 12-Months
Asset Growth
-14.68%
Trailing 12-Months
Company Description
DENTSPLY SIRONA Inc
DENTSPLY SIRONA (XRAY) is a leading global dental products and technologies company, specializing in the development and manufacturing of a wide range of dental solutions. The company operates in various sectors, including dental consumables, dental equipment, and dental technology, with core products that include dental imaging systems, CAD/CAM systems, and restorative materials. DENTSPLY SIRONA is dedicated to improving oral health by providing innovative solutions that enhance the efficiency and effectiveness of dental practices worldwide.
XRAY Company Deck
XRAY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
The earnings call highlighted significant challenges, including a decline in global and U.S. sales, an impairment charge, and a drop in EPS. While there were positive aspects such as growth in European sales and Wellspect Healthcare, these were overshadowed by the broader financial difficulties and strategic challenges. The sentiment is more negative due to the pressing issues and the focus on a turnaround strategy.View all XRAY earnings summariesXRAY Net sales Breakdown
14.58% Equipment & Instruments
13.42% CAD/CAM
38.33% Essential Dental Solutions
7.88% Orthodontics
17.77% Implants & Prosthetics
8.01% Wellspect Healthcare
XRAY Stock 12 Month Forecast
Average Price Target
$13.27
▲(17.64% Upside)
Technical Analysis
Ownership Overview
0.48% Insiders
31.06% Mutual Funds
36.84% Other Institutional Investors
11.22% Public Companies and
Individual Investors